Progressive Q1 Earnings Rise, Above Estimates

Auto insurance company The Progressive Corp. (PGR) on Thursday reported higher earnings and revenues in the first-quarter, helped by an increase in net premiums earned. The company's results came in above the Street estimates.

The company posted first-quarter net income of $1.48 billion or $2.51 per share, up from $692.7 million or $1.17 per share in the same period last year.

On average, 18 analysts polled by Thomson Reuters expected the company to report earnings of $1.72 per share in the quarter. Analysts' estimates usually exclude one-time items.

Quarterly revenues rose 23 percent to $11.4 billion from $9.3 billion in the year-ago period. On average, 7 analysts expected the company to report revenues of $11.2 billion in the quarter.

During the quarter, net premiums earned was up 10 percent to $10.4 billion from $9.4 billion in the prior-year period. Net written premiums rose 19 percent to $11.7 billion from $9.8 billion a year ago.

The company's investment income declined 9 percent to $220.2 million from $241.2 million in the corresponding quarter last year.

Combined ratio was up 2.4 points during the quarter to 89.3 from 86.9 in the previous-year period.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Flavor maker McCormick & Co., Inc. is recalling certain McCormick and Frank's brand seasoning products citing possible salmonella risk, the U.S. Food and Drug Administration said. The recall involves McCormick Perfect Pinch Italian Seasoning, McCormick Culinary Italian Seasoning and Frank's RedHot Buffalo Ranch Seasoning. Drug major Pfizer Inc. raised Wednesday its outlook for fiscal 2021 earnings and revenues following strong second quarter results that exceeded market estimates. According to the company, the upward revision in full-year outlook, for the second quarter in a row, reflects its updated expectations for contributions to 2021 performance from both BNT162b2, the Pfizer-BioNTech SE COVID-19 vaccine. While reporting financial results for the second quarter on Wednesday, biopharmaceutical company Bristol-Myers Squibb Co. (BMY) reaffirmed its adjusted earnings and revenue growth guidance for the full-year 2021. For fiscal 2021, the company now projects earnings in a range of $3.18 to $3.38 per share,...
Follow RTT